40 results
8-K
EX-3.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
of this Corporation all rights incident to any and all securities of any other entity or entities standing in the name of this Corporation. The authority granted
424B3
GOSS
Gossamer Bio Inc
28 Aug 23
Prospectus supplement
4:29pm
of a counsel for the selling stockholders, blue sky fees and expenses and the expenses of any special audits incident to the registration.
Termination … to be made directly or through agents. We will not receive any of the proceeds from this offering.
We are required to pay all fees and expenses incident
S-3
2t1qvwbwzy8zuywo
18 Aug 23
Shelf registration
8:41am
S-3ASR
935uob4ms9xofyw3uo6h
17 Aug 23
Automatic shelf registration
4:01pm
S-3ASR
6ceudsnm 5caaw19b
9 Aug 22
Automatic shelf registration
12:00am
S-3ASR
el3cg6oixluh
3 Mar 22
Automatic shelf registration
4:05pm
8-K
EX-1.2
vvngnz ddo18qgnefb
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.1
1a9gbv
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
424B5
vcegs0gfaa2v9xv
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
19k3cv3o vvqsv
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
d1yk00ulm
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
w746b 8o7
18 May 20
Prospectus supplement for primary offering
4:11pm